Skip to contentSkip to Braille Studio

Library / Laws / 117th Congress / House Bills / H.R. 597

H.R. 597

To require any COVID–19 drug developed in whole or in part with Federal support to be affordable and accessible by prohibiting monopolies and price gouging, and for other purposes.

Print stageDateSize⠃
Introduced in House2021-01-2819.9K⠃⠗⠋